{"id":10200,"date":"2022-07-25T12:30:00","date_gmt":"2022-07-25T17:30:00","guid":{"rendered":"https:\/\/shockwavemedical.com\/news\/shockwave-medical-announces-details-for-conference-call-discussing-second-quarter-2022-results-and-participation-in-upcoming-investor-conference\/"},"modified":"2022-07-25T12:30:00","modified_gmt":"2022-07-25T17:30:00","slug":"shockwave-medical-announces-details-for-conference-call-discussing-second-quarter-2022-results-and-participation-in-upcoming-investor-conference","status":"publish","type":"news","link":"https:\/\/shockwavemedical.com\/ja\/news\/shockwave-medical-announces-details-for-conference-call-discussing-second-quarter-2022-results-and-participation-in-upcoming-investor-conference\/","title":{"rendered":"Shockwave Medical Announces Details for Conference Call Discussing Second Quarter 2022 Results and Participation in Upcoming Investor Conference"},"content":{"rendered":"\n<section id=\"block_448bfb3a36c56716fee78f3751724970\" class=\"block block--wysiwyg wysiwyg_styles u-bgColorNone container\">\n\t<div class=\"u-wysiwyg u-animation\">\n\t\t<p align=\"left\">SANTA CLARA, Calif., July 25, 2022 (GLOBE NEWSWIRE) \u2014 Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, will report financial results for the second quarter 2022 after market close on Monday, August 8, 2022. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time.<\/p>\n<p>On Wednesday, August 10, 2022, at 3:00 p.m. Eastern Time, Shockwave Medical management is scheduled for a fireside chat at the Canaccord Genuity 42<sup>nd<\/sup>\u00a0Annual Growth Conference, which is taking place from Monday, August 8 \u2013 Thursday, August 11, 2022 at the InterContinental Hotel in Boston, MA.<\/p>\n<p>To access the live second quarter 2022 earnings call via telephone, please register in advance using the link\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0lGm1L5z2D3eZ65kwKZfeMh1X1PerDKKU9eaBy4ndW71rfI3KYN4ZkM6Q617kcLBgXkuFPASflPy4_5XqIm8b21bCAYJ-KXD7axJQKka9bhNg1iYxVN7nBPDuEZq53_usSbweInjiZjv8KWSByIreg==\" target=\"_blank\" rel=\"nofollow noopener\">here<\/a>. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique personal PIN that can be used to join the call.<\/p>\n<p><strong>About Shockwave Medical, Inc.\u00a0<\/strong><\/p>\n<p>Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which the company refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes. To view an animation of the IVL procedure and for more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dj7__wq1Q88q5d56x9O-FBm_eXfFaAoTEnSKZAsWpnzuwj9Gs89yN2WdAaK-oHXLqulejEL2XAvANh5rqzvrMGqTRGsnEQHEYn0ahuD4LZ4=\" target=\"_blank\" rel=\"nofollow noopener\">www.shockwavemedical.com<\/a>.<\/p>\n<p>Media Contact:<br \/>\nScott Shadiow<br \/>\n+1.317.432.9210<br \/>\n<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uKTEBL4gjgyBRiOFpiJYXFxQ2TDfLIdEB2Rt9NizLheu8vXjGagt3eI4SSVJZChxaqGAhHKHN8a9zDEpLpce9CteS1cfTMoANtvKGMzVI0G9ahcuE7X3jT5vAkBfkt32\" target=\"_blank\" rel=\"nofollow noopener\">sshadiow@shockwavemedical.com<\/a><\/p>\n<p>Investor Contact:<br \/>\nDebbie Kaster<br \/>\n<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=arPPuf3QxlyvsAR_HFo43ucgkmWKWQEpalb_EfaFOISfSQguHTRec7bITq5_qxDYZFgZ_31nQkZ1Q7mP5kmXT-_18jeRcJTSe30wlApYyr2fO5Y7bOWFN00jJQu_9q1M\" target=\"_blank\" rel=\"nofollow noopener\">investors@shockwavemedical.com<\/a><\/p>\n\t<\/div>\n\t<\/section>","protected":false},"excerpt":{"rendered":"<p>Shockwave Medical, Inc. will report financial results for the second quarter 2022 after market close on Monday, August 8, 2022.<\/p>\n","protected":false},"featured_media":9944,"template":"","format":[],"meta":{"_acf_changed":true,"content-type":""},"disease-state":[],"news-topic":[],"product-tag":[],"specialty":[],"technology":[],"class_list":["post-10200","news","type-news","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/news\/10200","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/media\/9944"}],"wp:attachment":[{"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/media?parent=10200"}],"wp:term":[{"taxonomy":"disease-state","embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/disease-state?post=10200"},{"taxonomy":"format","embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/format?post=10200"},{"taxonomy":"news-topic","embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/news-topic?post=10200"},{"taxonomy":"product-tag","embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/product-tag?post=10200"},{"taxonomy":"specialty","embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/specialty?post=10200"},{"taxonomy":"technology","embeddable":true,"href":"https:\/\/shockwavemedical.com\/ja\/wp-json\/wp\/v2\/technology?post=10200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}